Small Molecules

15 Aug 2007 Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
15 Aug 2007 Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
15 Aug 2007 Accentia Biopharmaceuticals Updates Interim Analysis of Blinded Clinical Results in the Fast-Tracked Pivotal Phase 3 Trial of SinuNase for the Treatment of Refractory Chronic Sinusitis
15 Aug 2007 Urigen Pharmaceuticals, Inc. Initiates URG101-104 Phase II Pharmacodynamic Clinical Trial for Painful Bladder Syndrome/Interstitial Cystitis
15 Aug 2007 Phase II clinical trial results for ADENTRI published in “Journal of the American College of Cardiology”
15 Aug 2007 Icagen Announces Alliance with Pfizer in Ion Channel-Focused Therapeutics for Pain and Related Disorders
15 Aug 2007 Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
15 Aug 2007 NeurAxon Announces Positive Phase 1 Trial Data on NXN-188 for Migraine
15 Aug 2007 CombinatoRx announces initiation of phase 2a proof-of-concept clinical study with CRx-401 for Type 2 diabetes
15 Aug 2007 Cytokinetics announces the initiation of a phase I clinical trial for GSK-923295
15 Aug 2007 GlaxoSmithKline updates prescribing information for Avandia in the US
14 Aug 2007 Cipher provides CIP-ISOTRETINOIN regulatory update
14 Aug 2007 Avigen Initiates U.S. Clinical Development for AV411
12 Aug 2007 LifeCycle Pharma and Sciele Pharma announce FDA approval of new formulation of Fenofibrate in 120 mg. and 40 mg. dosage strengths
11 Aug 2007 Wyeth Pharmaceuticals and Solvay Pharmaceuticals, Inc. announce receipt of an FDA action letter for bifeprunox, an investigational treatment for schizophrenia
11 Aug 2007 TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
11 Aug 2007 Potential safety issue identified in ongoing phase 2 clinical study of HCV-796
11 Aug 2007 UK High Court ruled NICE Guidence for Alzheimer's disease discriminatory
11 Aug 2007 FDA approves IND for phase II studies of TASQ
10 Aug 2007 Biovail enters into license and development agreement
10 Aug 2007 GSK receives decision from FDA on Advair 500/50 for COPD
10 Aug 2007 DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10 Aug 2007 Sirtris Pharmaceuticals, Inc. Announces Initiation of Phase 1b Clinical Trial of SRT501 in MELAS
10 Aug 2007 Spectrum Pharmaceuticals Investigational New Drug Application for SPI-1620 Cleared by U.S. Food & Drug Administration
10 Aug 2007 Phase I intravenous trial for anti-cancer drug achieves primary objectives

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up